Indivior Swings To Annual Loss On Higher Costs And Lower Revenue
Indivior Swings To Annual Loss On Higher Costs And Lower Revenue
Read moreIndivior Swings To Annual Loss On Higher Costs And Lower Revenue
Read more(Sharecast News) - Indivior plunged to an annual loss as the opioid addiction treatment maker's Suboxone drug lost market share and the company settled litigation related to the US opioid crisis.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreBROKER RATINGS: Barclays Cuts Babcock To Underweight From Overweight
Read moreLONDON MARKET CLOSE: Stocks Rise As IMF Lifts Global Growth Outlook
Read moreLONDON MARKET MIDDAY: FTSE 100 Charges Ahead Even As Rolls-Royce Drags
Read moreTOP NEWS: Indivior Reaches Settlement with Reckitt Benckiser
Read moreLONDON MARKET CLOSE: Red End To Glum Week As Biden Unveils US Aid Plan
Read moreLONDON MARKET MIDDAY: Down After Biden Aid Plan; US Bank Results Due
Read moreUK WINNERS & LOSERS SUMMARY: Indivior Rises After Raising Guidance
Read moreIndivior Raises Annual Guidance As Sublocade Sales Exceed Expectations
Read moreLONDON MARKET OPEN: Aveva Rises As Revenue Jumps On Contract Renewals
Read moreLONDON MARKET PRE-OPEN: Indivior Raises 2020 Revenue Guidance
Read moreUK EXECUTIVE CHANGE SUMMARY: M&G Chair Evans Takes Temporary Break
Read moreUK WINNERS & LOSERS SUMMARY: Tremor Surges On Guidance Upgrade
Read more